PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 50 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

2 March 2025

  1. (diff | hist) m b 05:39 Dipeptidyl peptidase-4 5,763 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) 03:32 Shanghai Sigma-Audley New Material Technology 7,016 +347 SortKeySascha (talk | contribs) split overlong sentence [rollback]

1 March 2025

  1. (diff | hist) 20:45 FLOW trial 3,169 ±0 MassSpecMarv (talk | contribs) expand §Results [rollback]
  2. (diff | hist) 19:48 Sangon Biotech 5,945 +643 BlindSampleBrid (talk | contribs) expand §Independent testing record [rollback]
  3. (diff | hist) 15:11 Peptide harm reduction 2,785 ±0 BlankVialBo (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 14:04 Blind sampling 6,780 +1,130 SupplyWatchSuri (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  5. (diff | hist) m 13:23 ChinaPeptides 7,013 +144 IncretinIvo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  6. (diff | hist) m 07:54 Retatrutide 5,700 ±0 Chromatokid (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  7. (diff | hist) 07:08 Active pharmaceutical ingredient 2,868 +36 PharmDrafts (talk | contribs) expand §The regulatory frame [rollback]
  8. (diff | hist) m b 04:58 Dose escalation schedule 3,632 +122 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) 03:11 PeptideMeter 3,734 ±0 SurvodutideSaff (talk | contribs) state that the report identifies the sample, not the shipment [rollback]
  10. (diff | hist) 00:32 Subcutaneous injection 4,039 ±0 UnitsUrsula (talk | contribs) ce [rollback]

28 February 2025

  1. (diff | hist) m 23:23 Crude peptide 3,651 ±0 CrudePeptidePearl (talk | contribs) copyedit [rollback]
  2. (diff | hist) 11:07 Glucose-dependent insulinotropic polypeptide 6,686 ±0 TrialsTabitha (talk | contribs) copyedit [rollback]
  3. (diff | hist) 08:57 Shanghai Wibson Biotechnology 5,316 +979 VerifyVesna (talk | contribs) serial comma per PP:MOS [rollback]
  4. (diff | hist) 05:43 Tirzepatide 6,329 +95 OralSemaOswin (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  5. (diff | hist) 03:44 Glossary of peptide terminology 3,581 ±0 ColdChainCleo (talk | contribs) de-orphan [rollback]
  6. (diff | hist) 03:30 MOTS-c 2,663 ±0 TB500_Tarquin (talk | contribs) add a hatnote separating this from the fragment of the same parent protein [rollback]
  7. (diff | hist) m 02:05 Guangzhou JEEP Biotechnology 9,660 +839 BatchNumberBede (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]

27 February 2025

  1. (diff | hist) m 15:25 Regulatory status by jurisdiction 3,277 +556 DMF_Dermot (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  2. (diff | hist) 11:56 Lyophilisation 17,642 ±0 ToleranceTove (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  3. (diff | hist) m 06:17 Chinese Peptide Company 9,501 +256 EndotoxinEd (talk | contribs) ce per PP:MOS [rollback]

26 February 2025

  1. (diff | hist) m 22:40 Growth hormone secretagogue 3,433 +83 KPV_Kester (talk | contribs) rm the aggregate purity claim — no source, and no such survey exists [rollback]
  2. (diff | hist) 22:24 Reference standard 4,120 ±0 TFA_Counterion (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  3. (diff | hist) m b 19:38 Purity claim inflation 3,603 ±0 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  4. (diff | hist) 17:11 Incretin effect 5,425 ±0 SchematicScout (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  5. (diff | hist) 13:25 Melanotan II 3,358 ±0 DisclosureDido (talk | contribs) rm "clinically proven" — nothing cited supports the phrase [rollback]
  6. (diff | hist) m 12:40 Beta cell function 4,916 +588 LeanMassLars (talk | contribs) rm a duplicated category [rollback]
  7. (diff | hist) 12:07 Janoshik Analytical 4,126 ±0 Peptide_Pete (talk | contribs) rm the inference from one report to a supplier [rollback]
  8. (diff | hist) m b 11:28 Missed dose 4,123 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  9. (diff | hist) N 09:00 Flourishglobal Peptide Biotech 2,137 +2,137 TierTwoTansy (talk | contribs) start organisation article — registry facts and product scope only
  10. (diff | hist) 08:18 Hunan Aslsen Technology 7,721 ±0 TrialsTabitha (talk | contribs) expand §Ordering and availability [rollback]
  11. (diff | hist) m b 07:19 Multi-dose vial 4,366 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  12. (diff | hist) 04:23 Glucagon 5,754 +841 TirzTaxonomist (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]

25 February 2025

  1. (diff | hist) 18:00 Grey market 2,576 ±0 Chromatokid (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  2. (diff | hist) m b 17:46 Survodutide 4,005 +32 ArchiveBot (talk | contribs) bot: add drug-class category [rollback]
  3. (diff | hist) m 16:46 Good manufacturing practice 3,548 ±0 GreyMarketGreer (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  4. (diff | hist) 13:09 CagriSema 3,887 +111 ComparisonCato (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 12:54 Beyond-use date 11,093 +618 SharpsSukhi (talk | contribs) add a second worked example at a different vial strength [rollback]
  6. (diff | hist) m b 08:03 Chain of custody 3,916 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) m 04:09 Repackaging 3,958 +21 CustomsClarke (talk | contribs) expand §Repackaging as a market structure [rollback]
  8. (diff | hist) 03:54 Reverse-phase HPLC 4,246 ±0 BlindSampleBrid (talk | contribs) expand §Reading a reported determination [rollback]
  9. (diff | hist) m 03:34 Patent expiry and biosimilars 3,173 +595 BUD_Bertram (talk | contribs) add the date the shortage listing ended [rollback]
  10. (diff | hist) 02:38 Contract development and manufacturing organisation 3,462 +587 AnalyticalAnnie (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]
  11. (diff | hist) 00:27 Tianjin Finder Chemical 6,469 +301 eGFR_Esme (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]

24 February 2025

  1. (diff | hist) m b 16:13 Liquid chromatography-mass spectrometry 3,451 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  2. (diff | hist) m 15:49 Prescribing information 3,458 ±0 DEXA_Dilys (talk | contribs) expand §Structure [rollback]
  3. (diff | hist) m 15:09 Fasting insulin 2,962 ±0 B12_Bettina (talk | contribs) expand §Behaviour under treatment [rollback]
  4. (diff | hist) 14:22 Amylin 4,252 +296 TrialsTabitha (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  5. (diff | hist) 04:25 Sarcopenia 2,738 ±0 B12_Bettina (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  6. (diff | hist) 03:12 Trial data comparison 2,835 +439 MergeMorwenna (talk | contribs) correct the column header — that column is volume [rollback]
  7. (diff | hist) 03:05 Loss on drying 3,735 +397 KarlFischerKit (talk | contribs) expand §Why the distinction from water matters [rollback]
  8. (diff | hist) m 01:16 Insulin syringe 4,111 ±0 DeadSpaceDot (talk | contribs) add a second worked example at a different vial strength [rollback]

23 February 2025

  1. (diff | hist) 23:06 Retention time 3,306 ±0 AAA_Analyst (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) m b 19:56 Counterfeit peptide 2,733 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m 19:45 Contraindications of incretin therapy 3,408 +34 Chromatokid (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 15:09 Cagrilintide 3,187 +40 IcodecIndra (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  5. (diff | hist) 13:52 Intention-to-treat analysis 3,795 ±0 EndpointEnid (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  6. (diff | hist) m 11:23 Drug master file 3,076 +811 FiveOhThreeB (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) 10:03 Peptide synthesis 4,113 ±0 FerritinFay (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  8. (diff | hist) m 10:02 Underfilling 2,520 +32 ForestPlotFinn (talk | contribs) state what the certificate actually carries, field by field [rollback]
  9. (diff | hist) 09:16 Nantong Guangyuan Chemical 8,995 +874 UnderfillUna (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  10. (diff | hist) 03:04 Karl Fischer titration 6,559 ±0 AnalyticalAnnie (talk | contribs) add the detection wavelength [rollback]
  11. (diff | hist) m b 02:42 Trifluoroacetate counterion 3,489 +25 StubSorterBot (talk | contribs) bot: sort category members [rollback]

22 February 2025

  1. (diff | hist) 21:10 Peptide supply chain 5,316 +135 NPOV_Nadia (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) 21:07 Research use only 6,689 ±0 FmocFrancis (talk | contribs) state that a GMP claim is not a fact until assessed [rollback]
  3. (diff | hist) 09:58 Enteroendocrine L cell 4,619 ±0 FiveOhThreeB (talk | contribs) add the reference range with the assay it was established on [rollback]
  4. (diff | hist) m b 08:18 Weight regain after discontinuation 4,031 +335 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  5. (diff | hist) 00:37 Wuhan Wansheng Biotechnology 9,768 +529 ForgeryFinder (talk | contribs) alphabetise the see-also list [rollback]
  6. (diff | hist) m 00:31 Peptide aggregation 4,028 +127 PreregPriya (talk | contribs) add the reference standard and its traceability [rollback]

21 February 2025

  1. (diff | hist) m b 22:29 GL Biochem (Shanghai) 10,795 +483 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  2. (diff | hist) m 22:21 Sterile water for injection 3,619 ±0 GramsNotUnitsGil (talk | contribs) give the worked example to two significant figures throughout [rollback]
  3. (diff | hist) m 19:45 Arcuate nucleus 4,321 +447 LCellLeif (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  4. (diff | hist) 19:27 Peptide content 6,078 +1,146 DiluentDiya (talk | contribs) add the equilibration time to the gradient description [rollback]
  5. (diff | hist) m b 17:46 Deamidation 3,531 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  6. (diff | hist) m b 16:25 Satiety signalling 4,441 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 04:05 TRIUMPH trial programme 3,495 ±0 COA_Colwyn (talk | contribs) typo [rollback]
  8. (diff | hist) m 02:36 Prior authorisation 2,250 ±0 ShortageShona (talk | contribs) convert the country price comparison to a table with a common currency [rollback]
  9. (diff | hist) 02:16 Oral semaglutide 3,519 ±0 DulaglutideDug (talk | contribs) fix the anchor on an internal link [rollback]
  10. (diff | hist) m 00:31 Body composition assessment 4,060 +707 A1c_Alder (talk | contribs) rm the extrapolation from a research assay to a clinical one [rollback]
  11. (diff | hist) m b 00:09 Mass spectrometry 4,327 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]

20 February 2025

  1. (diff | hist) m 23:52 Area percent purity 6,569 +544 TallySheetTad (talk | contribs) add the plate-count expression and define its terms [rollback]
  2. (diff | hist) m 23:26 Bacteriostatic water 3,824 ±0 SyringeSybille (talk | contribs) fix a broken wikilink [rollback]
  3. (diff | hist) m 21:27 Vial filling and stoppering 3,667 +312 ForestPlotFinn (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 18:28 USP General Chapter 71 2,970 +35 LOD_Lorcan (talk | contribs) fix hyphenation per PP:MOS [rollback]
  5. (diff | hist) m 17:08 Resin cleavage 3,277 ±0 CrudePeptidePearl (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  6. (diff | hist) 15:14 Solid-phase peptide synthesis 4,279 ±0 BlankVialBo (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  7. (diff | hist) m 14:11 Aspiration risk under anaesthesia 3,725 +117 SPPS_Sorrel (talk | contribs) split the gastrointestinal effects from the metabolic ones [rollback]
  8. (diff | hist) 11:48 Talk:GL Biochem (Shanghai) 1,170 +177 CDMO_Caradoc (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  9. (diff | hist) 09:18 Talk:Area percent purity 959 +121 PeakShapePol (talk | contribs) /* Detection wavelength: 214 or 220? */ reply
  10. (diff | hist) 07:14 Certificate of analysis 6,396 ±0 ManualOfStyleMo (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  11. (diff | hist) m 06:33 Receptor bias 3,517 +281 TitrationTheo (talk | contribs) consistent en dashes in ranges [rollback]
  12. (diff | hist) 04:03 Cost per milligram 2,123 ±0 TierTwoTansy (talk | contribs) rm the specific plan recommendation; out of scope [rollback]
  13. (diff | hist) m b 01:45 Third-party testing 5,770 +683 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]

19 February 2025

  1. (diff | hist) 20:14 Residual solvent 3,736 ±0 KarlFischerKit (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  2. (diff | hist) 20:06 Exenatide 4,288 +869 Chromatokid (talk | contribs) add category for the drug class [rollback]
  3. (diff | hist) 18:22 Shanghai Wibson Biotechnology 4,337 +1,443 CheckSumChase (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  4. (diff | hist) 15:44 Talk:Area percent purity 748 +274 GradientGus (talk | contribs) /* Detection wavelength: 214 or 220? */ reply
  5. (diff | hist) 14:22 List of GLP-1 receptor agonists 3,023 ±0 DefinedTermDov (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 11:49 Bacterial endotoxin test 4,398 ±0 TitrationTheo (talk | contribs) close an unbalanced quotation mark [rollback]